Regulaxis’ President Claude Carelli and the COO Christelle Vêtu participated to the RDV PME by Le Figaro Economie
This interview is focused on the research and development in the field of bioscience. In particular Regulaxis present a new innovative compound, REGO3, for the treatment of arthroses.
Follow the full article to Le Figaro Economie


 2013 – Innovation Days One of 15 finalists « Innovation Prize » Universal Biotech.
2013 – Innovation Days One of 15 finalists « Innovation Prize » Universal Biotech. 
															 
									
Leave A Comment